Daiichi Sankyo has received FDA approval to package product at its first U.S.-based packaging facility, located in Bethlehem, PA. The approval expands DS’ global supply chain capability. The 140,000-sq.-ft. facility will package some of the company’s portfolio of marketed products for cardiovascular and metabolic therapies, including treatments for hypertension and heart disease, diabetes and hyperlipidemia. In future, the facility could assume additional responsibilities related to...